{"filing":{"accession_number":"0001832511-26-000036","cik":"0001832511","ticker":"PIIIW","company_name":"P3 Health Partners Inc.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-09-04","primary_document":"piii-20260904.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000036/piii-20260904.htm"},"events":[{"id":32969,"run_id":30307,"accession_number":"0001832511-26-000036","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"P3 Health Partners entered into a Securities Purchase Agreement with CPF affiliates to issue up to $70 million of units consisting of Series D-1 Preferred Stock and warrants to purchase Common Stock under Section 4(a)(2) exemption. The warrants represent a dilutive equity issuance exercisable for approximately 0.66333% of outstanding Common Stock per $1 million funded, constituting a material unregistered private placement.","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36282,"accession_number":"0001832511-26-000036","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses unregistered sales of equity securities, which is the canonical trigger for dilutive_issuance classification. This event type covers private placements and other unregistered equity offerings that dilute existing shareholders and typically signal capital-raising activity, particularly material at smaller issuers like P3 Health Partners.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:28:55.693647+00:00","company_name":"","ticker":null,"filing_date":""},{"id":36283,"accession_number":"0001832511-26-000036","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Company entered into a Securities Purchase Agreement with CPF affiliates to issue up to $70 million of units consisting of Series D-1 Preferred Stock and warrants to purchase Common Stock. While the preferred stock itself is non-convertible and non-voting, the warrants represent a dilutive equity issuance exercisable for 0.66333% of outstanding Common Stock per $1 million funded, issued under Section 4(a)(2) exemption as an unregistered private placement. This is a material capital raise with dilutive equity components typical of PIPE-like transactions at mid-cap issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:28:55.693647+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":32970,"run_id":30307,"accession_number":"0001832511-26-000036","anchor_item_number":"1.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.45,"summary":"The Company entered into a material definitive agreement disclosed under Item 1.01, though the specific nature of the agreement (whether debt issuance, acquisition activity, or other strategic arrangement) cannot be determined without access to the full filing prose.","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36281,"accession_number":"0001832511-26-000036","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.45,"reasoning":"Item 1.01 typically covers material definitive agreements such as contracts, partnerships, or strategic arrangements. Without access to the specific prose of this filing, I cannot determine whether this agreement constitutes a debt issuance, acquisition activity, or other specific financial/operational event. The Item 1.01 designation and \"Material Definitive Agreement\" language suggest a material operational or strategic event, but the exact nature requires review of the actual agreement description in the filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:28:55.693647+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36281,"accession_number":"0001832511-26-000036","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.45,"reasoning":"Item 1.01 typically covers material definitive agreements such as contracts, partnerships, or strategic arrangements. Without access to the specific prose of this filing, I cannot determine whether this agreement constitutes a debt issuance, acquisition activity, or other specific financial/operational event. The Item 1.01 designation and \"Material Definitive Agreement\" language suggest a material operational or strategic event, but the exact nature requires review of the actual agreement description in the filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:28:55.693647+00:00","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-09-11"},{"id":36282,"accession_number":"0001832511-26-000036","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses unregistered sales of equity securities, which is the canonical trigger for dilutive_issuance classification. This event type covers private placements and other unregistered equity offerings that dilute existing shareholders and typically signal capital-raising activity, particularly material at smaller issuers like P3 Health Partners.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:28:55.693647+00:00","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-09-11"},{"id":36283,"accession_number":"0001832511-26-000036","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The Company entered into a Securities Purchase Agreement with CPF affiliates to issue up to $70 million of units consisting of Series D-1 Preferred Stock and warrants to purchase Common Stock. While the preferred stock itself is non-convertible and non-voting, the warrants represent a dilutive equity issuance exercisable for 0.66333% of outstanding Common Stock per $1 million funded, issued under Section 4(a)(2) exemption as an unregistered private placement. This is a material capital raise with dilutive equity components typical of PIPE-like transactions at mid-cap issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-11T20:28:55.693647+00:00","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-09-11"}]}